• About
  • Masthead
  • License Content
  • Advertise
  • Press Releases
  • Newsroom
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • Physician Pay by Specialty
    • ICD-10 Code Lookup
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • Physician Pay by Specialty
    • ICD-10 Code Lookup
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
2 Minute MedicineFree on Google PlayGet
✦EvidencePulse™by 2 Minute Medicine3 reportsYou askedtop stroke trials 2026Synthesizing medical evidence...Top 2026 stroke trial results:OCEANIC — ischemic stroke: 6.2% vs 8.4%OPTION* — mRS 0–1: 43.6% vs 34.2%ORIENTAL* — mRS 0–2: 58.6% vs 46.6%*Higher sICH in intervention armsParticipants randomizedNOCEANIC12,327OPTION570ORIENTAL564Ask about guidelines or landmark trials...↑Try EvidencePulse™Ask the evidence. Get the signal.Try it now →
Home All Specialties Imaging and Intervention

Arterial embolization successfully treats bleeding in anticoagulated patients

byBenjamin Laguna, MDandDylan Wolman
May 27, 2015
in Imaging and Intervention
Reading Time: 3 mins read
Blood type correlates with egg reserve in infertile women
Share on FacebookShare on TwitterShare on LinkedIn

1. Anticoagulated patients with soft tissue bleeding can successfully be treated with arterial embolization with a high degree of technical and clinical success. This is linked to reduced transfusion volume requirements.

2. Multiple detector computed tomography angiography is a sensitive technique for detecting soft tissue bleeding in suspected patients and selecting candidates for endovascular therapy.

Evidence Rating: 4 (Below Average)

Study Rundown: Anticoagulated patients are at higher risk for soft tissue hemorrhage, a potentially fatal and difficult to manage complication of such therapies. A lack of clear roles for medical management, surgery or endovascular directed therapies makes treatment controversial, and little data regarding best practices in anticoagulation-related bleeding exists. This retrospective case-series of anticoagulated patients who developed soft-tissue bleeding examined those who had undergone multiple detector computed tomography angiography (MDCTA) with subsequent endovascular embolization. The purpose of the study was to determine if arterial embolization of bleeding parent vessels may successfully and safely manage hemorrhage and to broadly examine the role of MDCTA in selecting such patients for endovascular treatment. Arterial embolization was technically successful in all of the 36 identified patients, and catheter angiography identified active bleeding in 75% of patients. Thirty patients were able to undergo MDCTA, which showed an overall sensitivity of 87% in detection of an active bleed. This study suggests that arterial embolization of patients is a feasible strategy for anticoagulated patients who develop soft-tissue bleeding. It also identifies MDCTA as a sensitive technique for detecting bleeding in suspected patients. This study was limited by its case-series nature, which lacked controls, and was further hindered by a relatively small sample size. Future studies would benefit from a larger, prospective controlled evaluation of patients undergoing arterial embolization, with a shorter time frame between MDCTA and intervention.

Click to read the study in the AJR (American Journal of Roentgenology)

Relevant reading: Relative Threshold of Detection of Active Arterial Bleeding: In Vitro Comparison of MDCT and Digital Subtraction Angiography

RELATED REPORTS

Apixaban (eliquis) outperforms Rivaroxaban (xarelto) in venous thromboembolism bleeding risk

2 Minute Medicine: Pharma Roundup – Pfizer’s Talzenna delays prostate cancer progression, apixaban lowers VTE bleeding risk, Lilly’s retatrutide hits Phase III metabolic targets, and FDA warns Novo Nordisk over safety reporting violations [March 2026]

In-Depth [case-series]: This single center study retrospectively identified 36 patients that developed soft-tissue bleeding on anticoagulation and underwent arterial embolization. Of these, 30 of 36 underwent MDCTA, which detected bleeding in 22 of 30 (73%), with an overall sensitivity of 87% as compared to standard catheter angiography. Catheter angiography was able to detect extravasation in 27 of 36 patients (75%), although there were 2 patients in whom bleeding was identified on MDCTA, but not seen on angiography. Due to the intermittent nature of anticoagulation-related hemorrhage, this was likely an angiographic false-negative, and not a false-positive of MDCTA. Nine of the 36 patients required a second embolization, but only one in the same vascular territory. Patients overall had a lower transfusion requirement after embolization, going from a median packed red blood cell requirement of 4 units (range, 0-12) to 0 units (range 0-4). Overall, 11 of the 36 patients died within 30 days, and there were no embolization-related complications identified. However, no reference standard existed to compare baseline mortality to, so the overall effect of arterial embolization on mortality could be determined.

Image: PD

©2015 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: anticoagulationmultiple detector computed tomography angiography
Previous Post

Heparin bridging may increase bleeding without preventing recurrent thromboembolism

Next Post

Antibiotic stewardship program for asymptomatic bacteriuria may be effective

RelatedReports

Drug comparison trials collage: a brass balance scale with white tablets on one pan and gray capsules on the other
Cardiology

Apixaban (eliquis) outperforms Rivaroxaban (xarelto) in venous thromboembolism bleeding risk

April 9, 2026
2 Minute Medicine: Pharma Roundup: Price Hikes, Breakthrough Approvals, Legal Showdowns, Biotech Expansion, and Europe’s Pricing Debate [May 12nd, 2025]
Endocrinology

2 Minute Medicine: Pharma Roundup – Pfizer’s Talzenna delays prostate cancer progression, apixaban lowers VTE bleeding risk, Lilly’s retatrutide hits Phase III metabolic targets, and FDA warns Novo Nordisk over safety reporting violations [March 2026]

March 30, 2026
Stroke recovery collage: a calm man in a sweater beside a brain with teal arteries, an empty speech bubble and a squeeze ball
Cardiology

Early anticoagulation after stroke decreases recurrence without increasing bleeding in patients with atrial fibrillation

July 29, 2025
#VisualAbstract: Reduced-Dose was Not Non-Inferior to Full-Dose Direct Oral Anticoagulants in Venous Thromboembolism Patients
StudyGraphics

#VisualAbstract: Reduced-Dose was Not Non-Inferior to Full-Dose Direct Oral Anticoagulants in Venous Thromboembolism Patients

March 10, 2025
Next Post

Antibiotic stewardship program for asymptomatic bacteriuria may be effective

Radiofrequency tags may safely localize nonpalpable breast lesions

Traffic noise exposure may be a risk factor for central obesity

✦ EvidencePulse™ by 2 Minute Medicine 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Large genetic association study identifies additional Alzheimer disease risk loci and candidate pathways
  • Pelacarsen lowers lipoprotein(a) but does not reduce major cardiovascular events in patients with established cardiovascular disease
  • Durvalumab plus enfortumab vedotin was approved for perioperative treatment of muscle-invasive bladder cancer
License Content
Terms of Use | Disclaimer
Cookie Policy

Get the app

Read 2 Minute Medicine on iPhone, iPad and Android.

Download on the App StoreGet it on Google Play
QR code for www.2minutemedicine.com/app
On a computer? Scan this with your phone’s camera.
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ new physician-written study summaries monthly, 12,000+ searchable
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
  • ✓FDA drug approvals + clinical calculators

Already a member? Sign in

  • Get the app
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • Physician Pay by Specialty
    • ICD-10 Code Lookup
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.